Pharma modernization initiatives stall not from lack of ambition but from expanding governance layers that distance ...
In today's ACT Brief, we explore why clinical trial diversity requires protocol redesign from the outset, the highest-impact ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher ...
In today's ACT Brief, we examine the technical and operational challenges of implementing risk-based monitoring across global ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research ...
In part 3 of this three-part series, behavioral science reveals that clinical trial diversity cannot be achieved through last ...
Global RBM requires interoperable architectures across EDC, IRT, eCOA, labs, imaging, EHR, and safety systems, but inconsistent CDISC/HL7 FHIR adoption and proprietary APIs impede near–real-time ...
In today's ACT Brief, we examine how real-world data is being applied across oncology, ophthalmology, and other therapeutic ...
C.K Wang, MD General Manager of Oncology & Chief Medical Officer Verana Health C.K. Wang is the General Manager of Oncology ...
In today's ACT Brief, we explore the leadership priorities that enable meaningful AI gains in clinical research, how Bayesian ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fish ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results